| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yanmei Li, Ruibing Su, Shuqin Xu, Qingjun Huang, Haiyun X. Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides. Neuropsychiatric disease and treatment. vol 13. 2020-10-01. PMID:29026311. |
clozapine is an atypical antipsychotic with therapeutic efficacy in treatment-resistant schizophrenia patients and low incidence of extrapyramidal side effects. |
2020-10-01 |
2023-08-13 |
rat |
| Zhen Liu, Changmeng Cui, Pengfei Xu, Ruili Dang, Hualin Cai, Dehua Liao, Mengqi Yang, Qingyan Feng, Xin Yan, Pei Jian. Curcumin Activates AMPK Pathway and Regulates Lipid Metabolism in Rats Following Prolonged Clozapine Exposure. Frontiers in neuroscience. vol 11. 2020-10-01. PMID:29046626. |
clozapine (clo) remains an ultimate option for patients with treatment resistant schizophrenia. |
2020-10-01 |
2023-08-13 |
rat |
| Ricardo de Oliveira-Souza, Rogério Paysano Marrocos, Jorge Mol. Clozapine for severe ("kraepelinian") schizophrenia: Sustained improvement over 5 years. Dementia & neuropsychologia. vol 2. issue 1. 2020-10-01. PMID:29213544. |
clozapine for severe ("kraepelinian") schizophrenia: sustained improvement over 5 years. |
2020-10-01 |
2023-08-13 |
Not clear |
| Ricardo de Oliveira-Souza, Rogério Paysano Marrocos, Jorge Mol. Clozapine for severe ("kraepelinian") schizophrenia: Sustained improvement over 5 years. Dementia & neuropsychologia. vol 2. issue 1. 2020-10-01. PMID:29213544. |
clozapine has become a keystone in the treatment of schizophrenia because of its efficacy as an antipsychotic with negligible neuroleptic effects. |
2020-10-01 |
2023-08-13 |
Not clear |
| Saeed Ahmed, Ali Mahmood Khan, Hema Madhuri Mekala, Hema Venigalla, Rizwan Ahmed, Amira Etman, Michael Esang, Mustafa Quresh. Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis. Heliyon. vol 3. issue 11. 2020-10-01. PMID:29264404. |
combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: a comparative meta-analysis. |
2020-10-01 |
2023-08-13 |
Not clear |
| Saeed Ahmed, Ali Mahmood Khan, Hema Madhuri Mekala, Hema Venigalla, Rizwan Ahmed, Amira Etman, Michael Esang, Mustafa Quresh. Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis. Heliyon. vol 3. issue 11. 2020-10-01. PMID:29264404. |
to assess the relative efficacies of clozapine plus electroconvulsive therapy (ect) compared against non-clozapine typical and atypical antipsychotics plus ect for the treatment of "treatment resistant schizophrenia" (trs). |
2020-10-01 |
2023-08-13 |
Not clear |
| Jacob A Lebin, Joshua D Villarreal, Betty C Chen, M Kennedy Hal. Clozapine Intoxication Mimicking Acute Stroke. Clinical practice and cases in emergency medicine. vol 2. issue 2. 2020-10-01. PMID:29849223. |
clozapine is an atypical antipsychotic drug prescribed for treatment-resistant schizophrenia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Thomas R E Barnes, Verity Leeson, Carol Paton, Louise Marston, David P Osborn, Raj Kumar, Patrick Keown, Rameez Zafar, Khalid Iqbal, Vineet Singh, Pavel Fridrich, Zachary Fitzgerald, Hemant Bagalkote, Peter M Haddad, Mariwan Husni, Tim Amo. Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial. Therapeutic advances in psychopharmacology. vol 8. issue 7. 2020-10-01. PMID:29977519. |
amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial. |
2020-10-01 |
2023-08-13 |
Not clear |
| S Al-Aojan, A Al-Khalifa. Clozapine-Induced Phototoxicity: An Unusual Side Effect of Atypical Antipsychotics. Case reports in dermatological medicine. vol 2018. 2020-10-01. PMID:30046495. |
clozapine is a second-generation antipsychotic used for treatment-refractory schizophrenia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Saeed Farooq, Abid Choudry, Dan Cohen, Farooq Naeem, Muhammad Ayu. Barriers to using clozapine in treatment-resistant schizophrenia: systematic review. BJPsych bulletin. vol 43. issue 1. 2020-10-01. PMID:30261942. |
barriers to using clozapine in treatment-resistant schizophrenia: systematic review. |
2020-10-01 |
2023-08-13 |
Not clear |
| Saeed Farooq, Abid Choudry, Dan Cohen, Farooq Naeem, Muhammad Ayu. Barriers to using clozapine in treatment-resistant schizophrenia: systematic review. BJPsych bulletin. vol 43. issue 1. 2020-10-01. PMID:30261942. |
aims and methodto systematically review the literature on barriers to the use of clozapine and identify any interventions for optimizing clozapine use in treatment-resistant schizophrenia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Shusuke Numata, Hidehiro Umehara, Tetsuro Ohmori, Ryota Hashimot. Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis. Frontiers in pharmacology. vol 9. 2020-10-01. PMID:30319405. |
clozapine pharmacogenetic studies in schizophrenia: efficacy and agranulocytosis. |
2020-10-01 |
2023-08-13 |
human |
| Shusuke Numata, Hidehiro Umehara, Tetsuro Ohmori, Ryota Hashimot. Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis. Frontiers in pharmacology. vol 9. 2020-10-01. PMID:30319405. |
clozapine is an efficacious atypical antipsychotic for treatment-refractory schizophrenia. |
2020-10-01 |
2023-08-13 |
human |
| Hannah Myles, Nicholas Myles, Ching Li Chai Coetzer, Robert Adams, Madhu Chandratilleke, Dennis Liu, Jeremy Mercer, Andrew Vakulin, Andrew Vincent, Gary Wittert, Cherrie Galletl. Cognition in schizophrenia improves with treatment of severe obstructive sleep apnoea: A pilot study. Schizophrenia research. Cognition. vol 15. 2020-10-01. PMID:30450286. |
the asset (assessing sleep in schizophrenia and evaluating treatment) pilot study investigated continuous positive airway pressure (cpap) treatment of severe osa in participants recruited from a clozapine clinic in adelaide. |
2020-10-01 |
2023-08-13 |
human |
| Kibrom Haile, Halima Ume. The use of clozapine and clonazepam co-administration in the treatment of a severe tardive dyskinesia: A case report. SAGE open medical case reports. vol 7. 2020-10-01. PMID:30834119. |
this is a case report of a patient who was treated with clozapine and clonazepam after he developed neuroleptic-induced tardive dyskinesia following treatment for schizophrenia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Deanna L Kelly, Raymond C Lov. Psychiatric pharmacist's role in overcoming barriers to clozapine use and improving management. The mental health clinician. vol 9. issue 2. 2020-10-01. PMID:30842912. |
clozapine is an antipsychotic that exhibits superior efficacy and effectiveness for those with schizophrenia and other serious mental illness. |
2020-10-01 |
2023-08-13 |
Not clear |
| Hongbo He, Yanling Zhou, Mingzhe Yang, Xiongxiong Li, Yu-Tao Xiang, Jiandong Lu. Comparison of Olanzapine versus Other Second-Generation Antipsychotics in the Improvement of Insight and Medication Discontinuation Rate in Schizophrenia. Shanghai archives of psychiatry. vol 30. issue 3. 2020-10-01. PMID:30858669. |
patients with schizophrenia on olanzapine were usually found to stay on their medications longer than the other second-generation antipsychotics (sgas) except clozapine. |
2020-10-01 |
2023-08-13 |
Not clear |
| Yuka Sugawara Kikuchi, Takashi Kanbayashi, Tetsuo Shimiz. Relationship between Clozapine-Induced Electroencephalogram Abnormalities and Serum Concentration of Clozapine in Japanese Patients with Treatment-Resistant Schizophrenia. Psychiatry investigation. vol 16. issue 4. 2020-10-01. PMID:30947495. |
relationship between clozapine-induced electroencephalogram abnormalities and serum concentration of clozapine in japanese patients with treatment-resistant schizophrenia. |
2020-10-01 |
2023-08-13 |
Not clear |
| In Won Chung, Seong Hoon Jeong, Hee Yeon Jung, Tak Youn, Se Hyun Kim, Yong Sik Ki. Long-Term Changes in Self-Report Auditory Verbal Hallucinations in Patients with Schizophrenia Using Clozapine. Psychiatry investigation. vol 16. issue 5. 2020-10-01. PMID:31132845. |
long-term changes in self-report auditory verbal hallucinations in patients with schizophrenia using clozapine. |
2020-10-01 |
2023-08-13 |
Not clear |
| In Won Chung, Seong Hoon Jeong, Hee Yeon Jung, Tak Youn, Se Hyun Kim, Yong Sik Ki. Long-Term Changes in Self-Report Auditory Verbal Hallucinations in Patients with Schizophrenia Using Clozapine. Psychiatry investigation. vol 16. issue 5. 2020-10-01. PMID:31132845. |
this study explored long-term changes in self-report auditory verbal hallucinations (avhs) among patients with schizophrenia taking clozapine. |
2020-10-01 |
2023-08-13 |
Not clear |